30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

INmune Bio Inc (INMB)

Track

Stock chart
Ticker: INMB Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Moss David J
Chief Financial Officer
1 purchase — total 52,868 USD
Buy 30 Sep 2024
Value US$4,947,490.93 | Price 35.26 | Shares 75,011
Buy 12 Sep 2024
Value US$4,584,282.50 | Price 98.31 | Shares 82,453
Buy 12 Sep 2024
Value US$49,023.75 | Price 6.38 | Shares 7,690
Buy 25 Jun 2024
Value US$36,350.00 | Price 7.27 | Shares 5,000
Buy 10 Nov 2023
Value US$48,650.00 | Price 6.95 | Shares 7,000
Planned sale 12 Jul 2023
Value US$110,085.00 | Price 11.01 | Shares 10,000
Proposed sale 12 Jul 2023
Value US$960,085.00 | Price 16.00 | Shares 60,000
Buy 17 Mar 2023
Value US$16,062.50 | Price 6.43 | Shares 2,500
Buy 27 May 2022
Value US$20,370.00 | Price 6.79 | Shares 3,000
Buy 26 May 2022
Value US$48,279.00 | Price 6.27 | Shares 7,700
Buy 26 May 2022
Value US$40,383.00 | Price 6.41 | Shares 6,300
Buy 17 Nov 2021
Value US$33,875.00 | Price 13.55 | Shares 2,500
Planned sale 3 Nov 2021
Value US$14,020.00 | Price 20.00 | Shares 701
Planned sale 3 Nov 2021
Value US$72,520.00 | Price 20.00 | Shares 3,626
Planned sale 3 Nov 2021
Value US$20,500.00 | Price 20.00 | Shares 1,025
Planned sale 27 Oct 2021
Value US$130,340.00 | Price 20.00 | Shares 6,517
Planned sale 27 Oct 2021
Value US$47,140.00 | Price 20.00 | Shares 2,357
Planned sale 27 Oct 2021
Value US$41,580.00 | Price 20.00 | Shares 2,079
Planned sale 25 Oct 2021
Value US$260.00 | Price 20.00 | Shares 13
Planned sale 22 Oct 2021
Value US$22,840.00 | Price 20.00 | Shares 1,142
Planned sale 22 Oct 2021
Value US$8,000.00 | Price 20.00 | Shares 400
Planned sale 22 Oct 2021
Value US$472,320.00 | Price 20.00 | Shares 23,616
Planned sale 8 Jul 2021
Value US$487,588.50 | Price 20.19 | Shares 24,150
Planned sale 7 Jul 2021
Value US$117,117.00 | Price 20.02 | Shares 5,850
Planned sale 14 Jun 2021
Value US$190,200.00 | Price 19.02 | Shares 10,000
Planned sale 31 Mar 2021
Value US$119,496.00 | Price 11.95 | Shares 10,000
Sale 27 Jan 2020
Value US$1,012,000.00 | Price 4.60 | Shares 220,000
Buy 11 Sep 2019
Value US$18,178.56 | Price 6.23 | Shares 2,918
Buy 21 Aug 2019
Value US$15,000.00 | Price 6.00 | Shares 2,500
Buy 20 Aug 2019
Value US$15,000.00 | Price 6.00 | Shares 2,500
Buy 20 Aug 2019
Value US$6,030.80 | Price 6.03 | Shares 1,000
Buy 20 Aug 2019
Value US$592.39 | Price 5.92 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$596.00 | Price 5.96 | Shares 100
Buy 20 Aug 2019
Value US$2,124.40 | Price 5.65 | Shares 376
Buy 20 Aug 2019
Value US$1,333.40 | Price 5.65 | Shares 236
Buy 20 Aug 2019
Value US$406.80 | Price 5.65 | Shares 72
Buy 20 Aug 2019
Value US$11,300.00 | Price 5.65 | Shares 2,000
Buy 20 Aug 2019
Value US$1,350.35 | Price 5.65 | Shares 239
Buy 20 Aug 2019
Value US$435.05 | Price 5.65 | Shares 77
Buy 9 Aug 2019
Value US$6,909.50 | Price 6.91 | Shares 1,000
Buy 9 Aug 2019
Value US$6,428.79 | Price 7.14 | Shares 900
Buy 9 Aug 2019
Value US$720.00 | Price 7.20 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-30 2024-09-30 B Purchase
3.7
Moss David J

Chief Financial Officer

Officer Large shareholder
75,011 -7.4%
35.26
US$4,947,491 		75,011 -7.4% 35.26 US$4,947,491
2024-09-16 2024-09-12 B Purchase
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
82,453 -2.3%
98.31
US$4,584,282 		82,453 -2.3% 98.31 US$4,584,282
2024-09-16 2024-09-12 B Purchase
3.7
Moss David J

Chief Financial Officer

Officer Large shareholder
83,788 -8.7%
440.80
US$4,371,021 		83,788 -8.7% 440.80 US$4,371,021
2024-06-26 2024-06-25 B Purchase
3.2
Juda Scott
Non-Executive Director
5,000 +7.5%
7.27
US$36,350 		5,000 +7.5% 7.27 US$36,350
2023-11-13 2023-11-10 B Purchase
3.2
Juda Scott
Non-Executive Director
7,000 +23.3%
6.95
US$48,650 		7,000 +23.3% 6.95 US$48,650
2023-07-14 2023-07-12 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -10.8%
11.01
US$110,085 		10,000 -10.8% 11.01 US$110,085
2023-07-12 2023-07-12 PrS Proposed sale
CTI Holdings, Inc

Director

Non-Executive Director
60,000
16.00
US$960,085 		60,000 16.00 US$960,085
2023-03-20 2023-03-17 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,500 +0.2%
6.43
US$16,062 		2,500 +0.2% 6.43 US$16,062
2022-05-31 2022-05-27 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
3,000 +0.2%
6.79
US$20,370 		3,000 +0.2% 6.79 US$20,370
2022-05-31 2022-05-26 B Purchase
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
7,700 +0.6%
6.27
US$48,279 		7,700 +0.6% 6.27 US$48,279
2022-05-31 2022-05-26 B Purchase
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
6,300 +0.4%
6.41
US$40,383 		6,300 +0.4% 6.41 US$40,383
2021-11-17 2021-11-17 B Purchase
3.2
Juda Scott
Non-Executive Director
2,500 +9.1%
13.55
US$33,875 		2,500 +9.1% 13.55 US$33,875
2021-11-04 2021-11-03 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
701 -0.0%
20.00
US$14,020 		701 -0.0% 20.00 US$14,020
2021-11-04 2021-11-03 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
3,626 -0.2%
20.00
US$72,520 		3,626 -0.2% 20.00 US$72,520
2021-11-04 2021-11-03 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
1,025 -0.1%
20.00
US$20,500 		1,025 -0.1% 20.00 US$20,500
2021-10-29 2021-10-27 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
6,517 -0.4%
20.00
US$130,340 		6,517 -0.4% 20.00 US$130,340
2021-10-29 2021-10-27 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
2,357 -0.2%
20.00
US$47,140 		2,357 -0.2% 20.00 US$47,140
2021-10-29 2021-10-27 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,079 -0.2%
20.00
US$41,580 		2,079 -0.2% 20.00 US$41,580
2021-10-26 2021-10-25 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
13 -0.0%
20.00
US$260 		13 -0.0% 20.00 US$260
2021-10-26 2021-10-22 PlS Planned sale
3.7
Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
1,142 -0.1%
20.00
US$22,840 		1,142 -0.1% 20.00 US$22,840
2021-10-26 2021-10-22 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer Large shareholder
400 -0.0%
20.00
US$8,000 		400 -0.0% 20.00 US$8,000
2021-10-26 2021-10-22 PlS Planned sale
3.1
Tesi Raymond Joseph

President and CEO

Executive Director Large shareholder
23,616 -1.5%
20.00
US$472,320 		23,616 -1.5% 20.00 US$472,320
2021-07-09 2021-07-08 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer
24,150 -1.6%
20.19
US$487,588 		24,150 -1.6% 20.19 US$487,588
2021-07-09 2021-07-07 PlS Planned sale
0.7
Lowdell Mark William

Chief Scientific Officer

Officer
5,850 -0.4%
20.02
US$117,117 		5,850 -0.4% 20.02 US$117,117
2021-06-15 2021-06-14 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -6.8%
19.02
US$190,200 		10,000 -6.8% 19.02 US$190,200
2021-04-01 2021-03-31 PlS Planned sale
Schroeder Timothy j
Non-Executive Director
10,000 -6.0%
11.95
US$119,496 		10,000 -6.0% 11.95 US$119,496
2020-01-29 2020-01-27 S Sale
0.8
Powers Linda F
Large shareholder
220,000 -51.2%
4.60
US$1,012,000 		220,000 -51.2% 4.60 US$1,012,000
2019-09-12 2019-09-11 B Purchase
0.7
Lowdell Mark William

Chief Scientific Officer

Large shareholder
2,918 +0.2%
6.23
US$18,179 		2,918 +0.2% 6.23 US$18,179
2019-08-22 2019-08-21 B Purchase Juda Scott Non-Executive Director
2,500 +10.0%
6.00
US$15,000 		2,500 +10.0% 6.00 US$15,000
2019-08-22 2019-08-20 B Purchase Juda Scott Non-Executive Director
2,500 +11.1%
6.00
US$15,000 		2,500 +11.1% 6.00 US$15,000
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
1,000 +0.1%
6.03
US$6,031 		1,000 +0.1% 6.03 US$6,031
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.92
US$592 		100 +0.0% 5.92 US$592
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
5.96
US$596 		100 +0.0% 5.96 US$596
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
376 +0.0%
5.65
US$2,124 		376 +0.0% 5.65 US$2,124
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
236 +0.0%
5.65
US$1,333 		236 +0.0% 5.65 US$1,333
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
72 +0.0%
5.65
US$407 		72 +0.0% 5.65 US$407
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
2,000 +0.2%
5.65
US$11,300 		2,000 +0.2% 5.65 US$11,300
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
239 +0.0%
5.65
US$1,350 		239 +0.0% 5.65 US$1,350
2019-08-21 2019-08-20 B Purchase Moss David J

CFO, Treasurer & Secretary

Officer Large shareholder
77 +0.0%
5.65
US$435 		77 +0.0% 5.65 US$435
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
1,000 +0.1%
6.91
US$6,910 		1,000 +0.1% 6.91 US$6,910
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
900 +0.1%
7.14
US$6,429 		900 +0.1% 7.14 US$6,429
2019-08-12 2019-08-09 B Purchase Tesi Raymond Joseph

President & CEO

Executive Director Large shareholder
100 +0.0%
7.20
US$720 		100 +0.0% 7.20 US$720
Explore more

More insider trading research around INmune Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America